切换至 "中华医学电子期刊资源库"

中华老年骨科与康复电子杂志 ›› 2020, Vol. 06 ›› Issue (02) : 111 -116. doi: 10.3877/cma.j.issn.2096-0263.2020.02.009

所属专题: 文献

骨质疏松

血清铁蛋白水平与骨密度的相关性研究
芦晶晶1, 李星1, 娄萍萍1, 张洁1, 刘岩1, 周亚茹1,()   
  1. 1. 050051 石家庄,河北医科大学第三医院内分泌科
  • 收稿日期:2019-11-09 出版日期:2020-04-05
  • 通信作者: 周亚茹
  • 基金资助:
    河北省重点研发计划国际科技合作专项(18397749D)

The relationship between Serum ferritin and Osteoporosis

Jingjing Lu1, Xing Li1, Pingping Lou1, Jie Zhang1, Yan Liu1, Yaru. Zhou1,()   

  1. 1. Departmen tof Endocrinology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China
  • Received:2019-11-09 Published:2020-04-05
  • Corresponding author: Yaru. Zhou
引用本文:

芦晶晶, 李星, 娄萍萍, 张洁, 刘岩, 周亚茹. 血清铁蛋白水平与骨密度的相关性研究[J/OL]. 中华老年骨科与康复电子杂志, 2020, 06(02): 111-116.

Jingjing Lu, Xing Li, Pingping Lou, Jie Zhang, Yan Liu, Yaru. Zhou. The relationship between Serum ferritin and Osteoporosis[J/OL]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2020, 06(02): 111-116.

目的

分析绝经后女性及50岁以上男性不同骨量人群血清铁蛋白的差异,探讨血清铁蛋白水平与骨密度的相关性。

方法

选择2018年9月至2019年2月期间于河北医科大学第三医院就诊,接受双能X线骨密度测量仪(DEXA)检测骨密度(BMD)的绝经后女性(131例)及50岁以上男性(65例)患者(共196例),根据BMD分为骨量正常组(46例)、骨量减少组(68例)和骨质疏松组(82例)。收集上述患者的临床资料,检测相关生化指标,并测定血清铁蛋白水平,评估血清铁蛋白与骨密度的相关性。

结果

(1)与骨量正常组[99.50(91.55,128.51)ng/ml]和骨量减少组[103.36(93.26,113.46)ng/ml]相比,骨质疏松组血清铁蛋白水平明显增高[(174.25(160.85,210.42)ng/ml)(χ2=100.573,P=0.000)。(2)血清铁蛋白水平与髋部、腰椎骨密度均呈负相关,(髋部r=-0.487,P<0.05;腰椎r=-0.531,P<0.05)。(3)体重为骨质疏松症的保护因素(r=0.049,P<0.05),血清铁蛋白为骨质疏松症的危险因素(r=-0.018,P<0.05)。

结论

血清铁蛋白水平增高是骨质疏松症的危险因素,在骨质疏松症的发生中可能起重要作用。

Objective

To analyze the difference of serum ferritin among postmenopausal women and men older than 50 years with different bone mass, and to explore the correlation between serum ferritin level and bone mineral density (BMD).

Methods

Postmenopausal women (n=131) and men (n=65) older than 50 years who received DEXA from September 2018 to February 2019 were enrolled in this study. They were divided into normal (46 cases), osteopenia (68 cases) and osteoporosis (82 cases) groups. Clinical data and biochemical parameters were collected. The level of serum ferritin was detected, and its correlation with BMDwas also determined.

Results

1.Compared with normal and osteopenia group, serum ferritin level was significantly increased in osteoporosis group [174.25 (160.85, 210.42) ng/ml vs. 99.50 (91.55, 128.51) ng/ml and 103.36 (93.26, 113.46) ng/ml, χ2=100.573, P<0.05]. 2. The level of serum ferritin was negatively correlated with BMD in hip and lumbar spine (hip r=-0.487, P<0.05; lumbar vertebrae r=-0.531, P<0.05). 3. Multivariate binary logistic regression analysis showed that body weight was the protective factor for osteoporosis (r=0.049, P<0.05), and serum ferritin was the risk factor for osteoporosis (r=-0.018, P<0.05).

Conclusion

Serum ferritin plays an important role in the prevalence of osteoporosis, which may be a risk factor for osteoporosis.

表1 各组受试者一般临床资料的比较
表2 各组受试者血清铁蛋白水平的比较
表3 不同年龄女性血清铁蛋白的比较
表4 三组受试者各部位BMD的比较(g/cm2±s
表5 血清铁蛋白水平与各因素的相关性
表6 血清铁蛋白与各因素的Logistic回归分析
1
Harvey NC, Biver E, Kaufman JM, et al. The role of Calcium supplementation in healthy musculoskeletal ageing:An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis,Osteoarthritis and Musculoskeletal Diseases(ESCEO)and the International Foundation for Osteoporosis(IOF) [J]. Osteoporos Int, 2017, 28(2): 447-462.
2
Lin X, Xiong D, Peng YQ, et al. Epidemiology and management of osteoporosis in the People's Republic of China:current perspectives [J]. Clin Interv Aging, 2015, 25(10): 1017-1033.
3
Kim BJ, Lee SH, Koh JM, et al. The association between higher serum ferritin level and lower bone mineral density is prominent in women≥45 years of age(KNHANES 2008-2010) [J]. Osteoporos Int, 2013, 24(10): 2627-2637.
4
Tsay J, Yang Z, Ross FP, et al. Bone loss caused by Iron overload in a murine model: importance of oxidative stress [J]. Blood, 2010, 116(14): 2582-2589.
5
Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group [J]. Osteoporos Int, 1994, 4(6): 368-381.
6
中国健康促进基金会骨质疏松防治中国白皮书编委会. 骨质疏松症中国白皮书[J]. 中华健康管理学杂志, 2009, 3: 148-154.
7
费蓓蓓,王啸,张弘, 等. 雌激素缺乏环境下铁蓄积对骨吸收及破骨细胞分化的影响[J]. 中华骨质疏松和骨矿盐疾病杂志, 2019, 12(02): 151-157.
8
Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari, Alexandros A. Drosos. Osteoporosis [M]. Springer International Publishing, 2018, 12-29.
9
Pinheiro MM, Reis N. Machado FS, et al. Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women [J]. Rev Saude Publica, 2010, 44(3): 479-485.
10
柴生颋,谢平金,万雷, 等. 体重及体质量指数与骨质疏松性骨折发生的关系研究[J]. 中国骨质疏松杂志, 2018, 24(02): 156-160.
11
Che J, Yang J, Zhao B, et al. The Effect of Abnormal Iron Metabolism on Osteoporosis [J]. Biol Trace Elem Res, 2019, Aug 31. [Epub ahead of print].
12
Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteoporosis and its clinical implications [J]. Osteoporos Int, 2012, 23(10): 2403-2408.
13
Weinberg ED. Iron loading: a risk factor for osteoporosis [J]. Biometals, 2006, 19(6): 633-635.
14
费蓓蓓. 雌激素对"铁蓄积导致骨代谢异常"的影响及作用机制的研究[D]. 苏州: 苏州大学, 2017.
15
15王啸. "铁蓄积"影响骨代谢的临床观察及分子机制[D]. 苏州: 苏州大学, 2018.
16
Galli C, Passeri G, Macaluso GF. Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena? [J]. J Periodontal Res, 2011, 46(4): 397-406.
17
Sun H, Huang Z, Wu P, et al. CDK6 and miR-320c Co-Regulate chondrocyte catabolism through NF-κB signaling pathways [J]. Cell Physiol Biochem, 2018, 51(2): 909-923.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 杨霁, 黄顺梅, 王安鸽, 吴月, 杨云梅. 杭州地区老年人群中肌少症患病情况及其与骨质疏松症的相关性分析[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(03): 207-210.
[3] 陆宜仙, 张震涛, 夏德萌, 王家林. 巨噬细胞极化在骨质疏松中调控作用及机制的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(06): 538-541.
[4] 陈跃圻, 罗睿, 向涵, 余泳妍, 余挺. 骨质疏松症与牙周炎的因果关系:一项两样本孟德尔随机化研究[J/OL]. 中华口腔医学研究杂志(电子版), 2023, 17(04): 292-298.
[5] 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 201-208.
[6] 宋红霞, 杨英, 陈芳. 老年COPD患者并发骨质疏松症相关危险因素的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(06): 895-898.
[7] 肖伍豪, 刘抗寒. 晚期慢性肾脏病患者骨质疏松症的治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 92-96.
[8] 冉仁国, 罗政, 廖鑫, 张付民. 低频脉冲电磁场对骨质疏松性胸腰椎骨折内固定术后康复的促进作用[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(01): 39-45.
[9] 张茜, 刘叶青, 康雪莹, 孙兵兵, 刘岩, 胡丽叶, 周亚茹. 血清铁蛋白与绝经后骨质疏松症的相关性分析[J/OL]. 中华老年骨科与康复电子杂志, 2023, 09(03): 166-171.
[10] 张青菊, 许建林, 南永刚, 施常备, 牛锦云. 99mTc-MDP SPECT/CT定量骨显像测定腰椎标准化摄取值的分析及应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 238-244.
[11] 周加军, 余永武, 周涵, 刘勇, 张凌. 甲状旁腺切除对继发性甲状旁腺功能亢进患者骨密度及骨代谢的影响[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 706-710.
[12] 田明达, 吴珺, 王会娟, 张欣, 沙玉英, 陈琳, 赵宾洋. 6297名0~3岁婴幼儿超声骨密度检测结果分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 644-647.
[13] 崔晓珊, 铁涛, 袁坤山, 孙钢, 张海军, 金鹏. 骨质疏松症及其椎体压缩骨折局部与全身一体化防治的动物实验研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 369-373.
[14] 邸文佳, 牛爱原. 基于东亚人群的肝硬化与骨质疏松症相关性研究[J/OL]. 中华老年病研究电子杂志, 2024, 11(01): 40-44.
[15] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
阅读次数
全文


摘要